FAB — Fusion Antibodies Share News
0.000.00%
- £7.16m
- £6.75m
- £1.14m
REG - Fusion Antibodies - Half-year Report
AnnouncementREG - AIM - AIM Notice - 22/10/2024
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementREG - Fusion Antibodies - Issue of shares to non-executive directors
AnnouncementREG - Fusion Antibodies - Result of AGM
AnnouncementREG - Fusion Antibodies - AGM statement and trading update
AnnouncementREG - Fusion Antibodies - Block admission six monthly return
AnnouncementREG - Fusion Antibodies - Notice of AGM
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementRCS - Fusion Antibodies - Investor presentation
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementREG - Fusion Antibodies - Final Results
AnnouncementRCS - Fusion Antibodies - Expansion to OptiMAL collaboration agreement
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementRCS - Fusion Antibodies - Launch of New Interactive Investor Hub
AnnouncementREG - Fusion Antibodies - Trading update
AnnouncementREG - Fusion Antibodies - New contract with existing client
AnnouncementRCS - Fusion Antibodies - Investor presentation
AnnouncementREG - Fusion Antibodies - Year-end trading statement
Announcement